Why Eczema and Rosacea Flare Up in Fall: A Canadian Doctor Explains the Triggers

Almost every fall, the same two questions come up in clinic: "Why does my eczema always get worse this time of year?" and "Why does my face turn red every time I walk outside?" Both feel like the same story: cold air, dry skin, angry skin, and skincare marketing tends to treat them that way too, with one "winter skin" narrative covering both.

The research doesn't support quite that tidy a story. Eczema (atopic dermatitis) has a genuinely substantial body of evidence linking cold, dry weather to worse barrier function and, in many populations, more flares, though even that evidence is less universal than it's often presented. Rosacea's connection to cold and wind is a well-recognized clinical observation, but the evidence base behind it is considerably thinner, and some of the biology commonly cited to explain it is still unproven in actual rosacea patients.

This article works through what's actually been demonstrated for each condition — where the evidence is strong, where it's genuinely mixed, and what's supported for managing both as fall settles in.

What's Actually Happening: Eczema vs. Rosacea in Cold Weather

Eczema (atopic dermatitis) is a barrier-dysfunction and immune-driven condition where the skin doesn't hold onto moisture as well as it should, combined with a lower threshold for inflammatory and allergic reactivity. Because it's fundamentally a barrier problem, it's biologically plausible that anything stressing the skin barrier further, like cold and dry air, would make it worse, and there's meaningful population-level evidence supporting that link.

Rosacea works differently. It's better understood as a condition of facial blood vessel reactivity and nerve sensitivity, with barrier dysfunction as one contributing factor rather than the core problem. Cold and wind are longstanding, clinically recognized rosacea triggers, but the underlying mechanism is still being worked out, and there isn't the same volume of population-level seasonal data behind it that exists for eczema.

Both conditions can genuinely worsen for some people as the weather turns. But "worse for some people" and "objectively worse for everyone every fall" are different claims, and the evidence only clearly supports the first one.

How Cold, Dry Air Affects the Skin Barrier

Cold air holds less moisture than warm air, and indoor heating strips out more of it a combination that measurably changes skin. In direct human studies, skin in winter shows higher transepidermal water loss (TEWL, a measure of how much water evaporates through the skin), altered surface pH, and shifts in the skin's protective lipids compared with the same skin in summer. Some of this is tied to reduced sebum production and a slowdown in how the skin secretes its own protective lipids in cold, dry conditions though not every study has found the same lipid changes, so this pathway is better supported than any single uniform mechanism.

In laboratory models, exposing skin cells to cooler-than-body-temperature conditions reduces production of filaggrin and loricrin (two proteins central to barrier structure) and triggers inflammatory signaling through a specific cold-sensing receptor pathway, a plausible biological explanation for why cold weather could aggravate eczema. But this is cell-culture and lab-model evidence, not direct proof that this exact pathway is driving flares in real patients during a Canadian winter.

For rosacea, the proposed mechanism is different and, honestly, less settled. Cold-sensing nerve receptors (such as TRPM8 and TRPA1) have been proposed as the link between cold exposure and the flushing rosacea patients describe. But a recent review looking specifically at this question concluded that direct evidence validating these receptors' role in rosacea remains limited, with much of the underlying science extrapolated from animal models of nerve pain rather than confirmed in human rosacea skin. That's a meaningfully different evidence tier than the eczema barrier research above, and it's worth knowing that when a "cold receptor" explanation for rosacea flares gets repeated as fact.

What Does the Clinical Evidence Actually Show?

Eczema: Real Population-Level Signal, But Not a Universal Rule

Several independent lines of evidence point in the same direction. A systematic review concluded that low humidity and low temperature reduce skin barrier function and raise susceptibility to irritants and allergens, and a large ecological study of over 90,000 children found eczema prevalence linked to lower outdoor temperature, lower humidity, lower UVB exposure, and more indoor heating use. A Danish study separately found that colder months correlated with more eczema clinic visits, hospitalizations, and prescriptions, independent of season timing. Helsinki primary-care data showed eczema diagnoses peaking in January through March and again in November, tracking with lower temperature and UV index — though notably, humidity itself wasn't significantly associated with that pattern in the Helsinki data, which complicates any simple "dry air alone" explanation.

Here's the part that gets left out of most seasonal-skincare content: when researchers have tried to pin down whether winter objectively worsens eczema severity across populations, the answer has been genuinely inconsistent. A 2025 meta-analysis rated the cold-versus-warm-season relationship with eczema severity as uncertain, with very low confidence, pointing to studies showing opposite seasonal patterns in different populations, including one study where flares were actually more common in the warm season and another showing higher odds of eczema presentation in the dry rather than cold season. Even within the same country, hospitalization data have shown winter peaks in colder regions, but summer peaks in warmer ones, and national outpatient visit data have actually peaked in late spring rather than winter. A separate review of 15 studies measuring TEWL seasonally found contradictory patterns, with some showing higher water loss in summer, others in fall and winter, depending on the body site studied and how the measurements were taken.

The most defensible summary: cold, dry climates like Canada's are a genuine risk factor for eczema flares at the population level, and the barrier-disruption mechanism behind that is well supported. But not everyone with eczema follows that pattern; some people are consistently summer-predominant, and the size of any seasonal effect varies by individual, region, and even which part of the body is affected.

Rosacea: Recognized Trigger, Thin Evidence Base

Cold and wind sit alongside heat, sunlight, stress, certain foods, and Demodex mites on the standard list of rosacea triggers, and that list reflects genuinely longstanding clinical observation. But when it comes to the kind of population-level, quantified seasonal data that exists for eczema studies actually measuring whether rosacea gets worse in winter, by how much, and in whom, that evidence simply isn't there in the current literature. What exists instead is a plausible model: cold, wind, dry air, and the constant transition between cold outdoor air and heated indoor air plausibly provoke flushing and irritation in skin that's already vascularly reactive and barrier-sensitive. That's a reasonable clinical hypothesis, not a demonstrated seasonal effect.

It's also worth directly countering a common oversimplification: rosacea isn't simply "dry skin." Barrier dysfunction is one contributing factor among several, alongside vascular reactivity, nerve sensitivity, microbial factors, UV exposure, and genetics,s not the sole cause. Rosacea is also more common in fair-skinned people of Celtic and northern European descent, a population well represented in Canada, though no Canadian-specific seasonal rosacea data exists to say how that translates into local flare patterns.

https://www.emjreviews.com/wp-content/uploads/2022/03/Infographic-Rosacea-awareness-01.jpg

Canadian Context

None of the specific studies behind these conclusions were conducted in Canada. The most relevant cold-climate data comes from Finland, Denmark, Central Europe, South Korea, and the northern United States places that share a temperate-to-cold winter climate with much of Canada, but shouldn't be assumed to translate exactly. The Helsinki data in particular, given Finland's climate similarity to much of Canada, is probably the closest available proxy for what a Canadian eczema-and-season pattern might look like, but it remains an extrapolation rather than direct evidence.

What Actually Helps: The Evidence on Moisturizers and Barrier Products

Ceramide Moisturizers Aren't Automatically Superior

This is one of the more useful, under-discussed findings in the evidence: ceramide-containing moisturizers are frequently marketed as the gold standard for eczema-prone skin, but a meta-analysis of five randomized trials found only a modest improvement in eczema severity scores with ceramide products over other moisturizers, and no significant difference in TEWL between the two. A separate randomized trial in children directly compared plain paraffin-based moisturizer against a ceramide-containing one and found essentially similar outcomes across severity, water loss, steroid use, and time to remission. That doesn't mean ceramide products don't work; a different adult trial did find a ceramide-dominant cream improved TEWL and hydration over a placebo, but it does mean "ceramides are essential" isn't a claim the current evidence firmly supports over simpler, well-formulated moisturizers.

Consistent Moisturizing Has Real, Meaningful Support

What is well supported is the basic habit of regular moisturizing itself. A Cochrane review of emollients and moisturizers for eczema found consistent use increased hydration and reduced dryness, itch, and flares, and lowered the need for anti-inflammatory medication, though the review authors also noted the overall trial evidence base was smaller than you'd expect for something this central to eczema care. A pooled analysis of two trials found a meaningful practical number: people who moisturized regularly had roughly a 60% lower relative risk of experiencing a flare over six months compared with those who didn't (about 26% versus 67%).

Humidifiers: Plausible, Not Proven

A common piece of fall advice is to run a humidifier to counter dry indoor heating. It's biologically reasonable since low indoor humidity is a recognized contributor to barrier stress, but there isn't a randomized trial in the available evidence directly testing whether humidifier use improves eczema outcomes. It's a defensible thing to try, but it shouldn't be presented as a proven fix.

Rosacea: Consensus Guidance, Not Trial-Tested for Season

For rosacea specifically, the guidance to use gentle, fragrance-free skincare and avoid known triggers like temperature extremes and wind reflects reasonable clinical consensus rather than a randomized trial testing a cold-weather intervention. That doesn't make it bad advice; it's the standard, sensible starting point, but it's a different evidence tier than the eczema-moisturizer data above.

Formulation and Label Guide

For eczema-prone skin, look for fragrance-free, non-soap cleansers with a neutral-to-low pH rather than traditional soaps, bubble baths, or foaming shower gels, and moisturizers with a shorter, simpler ingredient list. A "ceramide" claim on the label is a reasonable feature to look for but isn't, on the current evidence, a guarantee of superiority over a well-formulated basic moisturizer; the practical priority is finding a product you'll actually apply consistently, since consistency is what the strongest data supports.

For rosacea-prone skin, the same fragrance-free, gentle-formulation principle applies, with an emphasis on avoiding known irritant triggers (harsh exfoliants, alcohol-heavy toners, very hot water) rather than chasing a specific "rosacea" label claim, since ingredient-specific rosacea trial data for cold-weather use wasn't identified in this evidence base.

Building a Fall Routine

For eczema-prone skin, the best-supported habit is straightforward: moisturize liberally, generally two to three times daily, including right after bathing while skin is still slightly damp, since this is when moisturizer traps the most water at the surface. This is consensus dermatology guidance rather than a winter-specific trial finding, but it lines up with the flare-reduction data above. If skin is flaring despite consistent moisturizing, that's a signal to step up care rather than switch products repeatedly looking for a single "best" formula; the evidence doesn't support one clear winner among barrier moisturizers.

For rosacea-prone skin, minimizing rapid transitions between cold outdoor air and hot indoor air where practical, protecting the face from wind, and keeping the rest of the routine as gentle and fragrance-free as possible is the most defensible approach available, alongside general sun protection, since UV exposure is also a recognized trigger.

Common Mistakes and Myths Worth Avoiding

Assuming everyone's eczema gets worse in winter. Population-level data supports cold, dry climates as a risk factor, but individual patterns vary; some people are consistently summer-predominant, and seasonal severity data has been inconsistent across different populations and regions.

Believing a humidifier will reliably fix winter eczema. It's a reasonable, low-risk thing to try, but there's no randomized trial confirming it improves outcomes.

Assuming ceramide moisturizers are always superior to simpler ones. The comparative trial evidence shows the advantage, where it exists, is modest and inconsistent; a well-tolerated basic moisturizer used consistently may matter more than the specific lipid ingredients it contains.

Adding bath oils or antiseptic/antimicrobial additives to bath routines for eczema. The available evidence doesn't support either as beneficial add-ons.

Treating rosacea as "just dry skin." Barrier dryness is one contributing factor among several; vascular, nerve-related, microbial, UV, and genetic factors are all part of the picture, and treating rosacea as a pure moisture problem tends to undertreat it.

Citing cold-receptor biology (TRPM8/TRPA1) as a settled explanation for rosacea flares. It's a genuinely reasonable hypothesis, but current evidence validating these specific receptors in rosacea is limited and largely extrapolated from animal pain research rather than confirmed in human rosacea patients.

When to See a Doctor

For eczema, it's worth seeing a doctor rather than continuing to adjust products at home if flares are widespread or worsening despite consistent moisturizing; if there are signs of skin infection (spreading redness, warmth, oozing, or fever); if itching is disrupting sleep; or if over-the-counter care simply isn't controlling symptoms, prescription-strength anti-inflammatory options exist and are appropriate when basic care isn't enough.

For rosacea, a dermatology visit is worth it if facial redness or flushing is persistent and not settling with trigger avoidance, if visible blood vessels or bumps and pustules are worsening, or if there's eye irritation, grittiness, or redness alongside facial symptoms, since ocular involvement is a recognized feature of rosacea that benefits from specific treatment.

A Doctor's Take

The honest version of this topic is less tidy than most fall skincare guides make it sound. For eczema, there's real, defensible evidence that cold, dry climates raise flare risk at a population level, and the strongest thing we can actually offer patients consistent moisturizing has solid trial support behind it, including a meaningful reduction in flare risk. What doesn't hold up as well is the idea that any one moisturizer type, ceramide-containing or otherwise, is clearly superior; the comparative data just doesn't show a consistent winner. For rosacea, I'd be careful about presenting cold and wind as scientifically "proven" triggers with a fully worked-out mechanism; they're well-recognized clinically, which matters, but the receptor-level science often cited to explain them is still mostly unproven in actual rosacea patients. My practical advice for both conditions is the same: build a simple, consistent, fragrance-free routine before chasing a specific ingredient, and see a professional when over-the-counter care isn't keeping symptoms controlled.

The Bottom Line

Cold, dry fall and winter weather is a genuine, biologically plausible, and reasonably well-evidenced risk factor for eczema flares, but the evidence stops short of proving it worsens everyone's eczema, with real population and individual variability in seasonal patterns. Rosacea's connection to cold and wind is a longstanding, credible clinical observation, but it rests on a much thinner evidence base, without the seasonal population studies that exist for eczema and without solid human confirmation of the specific cold-sensing mechanisms often cited to explain it. For both conditions, consistent, gentle, fragrance-free skincare is well supported as a foundation, while chasing a single "best" winter ingredient, ceramides included, isn't strongly backed by the comparative evidence. When basic care isn't keeping either condition under control, that's a reasonable point to involve a doctor rather than keep adjusting products.

MiraGlow Products to Consider

The products below fit into the gentle, fragrance-free, barrier-supportive approach discussed above for both eczema- and rosacea-prone skin; they're general options to support a routine, not treatments for either condition. Formulations and availability can change, so it's worth checking MiraGlow's skincare collection directly before purchasing, and anyone with diagnosed eczema or rosacea should confirm a new product is a good fit for their skin before making it part of a routine.

• Gentle Face Cleanser with Hyaluronic Acid: A non-soap, hydrating cleanser that fits the fragrance-free, low-irritation approach discussed above for both conditions.
  

• Hydration Serum: Can be layered under a moisturizer as part of a simple, consistent fall routine, in line with the "consistency over complexity" approach the evidence points toward.

References

1. Engebretsen, et al. Systematic review of low humidity and low temperature effects on skin barrier function and atopic dermatitis flare risk. Journal of the European Academy of Dermatology and Venereology. 2016.

2. Systematic review of climate, indoor heating, and UVB exposure as reported aggravators of atopic dermatitis. The Lancet. 2025.

3. Ecological study of atopic dermatitis prevalence in over 90,000 children, associated with outdoor temperature, humidity, UVB index, and indoor heating use.

4. Cross-sectional study of transepidermal water loss and stratum corneum lipid composition in winter versus summer in Central European women.

5. Nationwide analysis of diurnal temperature range, humidity, and atopic dermatitis prevalence, South Korea.

6. Healthcare utilization study linking monthly temperature to atopic dermatitis clinic visits, hospitalizations, and prescriptions, Denmark.

7. Meta-analysis rating the certainty of cold-versus-warm-season associations with atopic dermatitis severity and prevalence as uncertain (very low certainty). JAMA Dermatology. 2025.

8. Remitz, et al. Primary care utilization study of atopic dermatitis diagnoses versus temperature, UV index, and humidity, Helsinki, Finland, 2018–2023. 2025.

9. Chan, et al. Pediatric cohort study of flare odds during cold weeks in atopic dermatitis. 2023.

10. Green, et al. Systematic review of 15 human studies measuring seasonal variation in transepidermal water loss. 2022.

11. Kim et al. Laboratory keratinocyte and organotypic skin model study of cool-temperature exposure, filaggrin/loricrin expression, and inflammatory signaling. 2022.

12. Montero-Vílchez et al. Cross-sectional study of transepidermal water loss and hydration in lesional versus non-lesional skin in 65 atopic dermatitis patients. 2021.

13. van Zuuren, E.J., Fedorowicz, Z., Christensen, R., Lavrijsen, A., Arents, B.W.M. Emollients and Moisturisers for Eczema. The Cochrane Database of Systematic Reviews. 2017.

14. Nugroho, et al. Meta-analysis of five randomized controlled trials comparing ceramide-containing moisturizers with other moisturizers in atopic dermatitis. 2023.

15. Gupta,et al. Randomized controlled trial comparing paraffin-based and ceramide-containing moisturizers in 53 children with mild-to-moderate atopic dermatitis. 2023.

16. Danby, t al. Randomized intrapatient trial of a physiologic lipid cream versus reference emollient in 34 adults with dry, eczema-prone skin. 2021.

17. Spada, et al. Randomized trial of a ceramide-dominant cream and cleanser regimen versus placebo in adults with moderate eczema. 2021.

18. Simpson, et al. Pragmatic randomized controlled trial of daily full-body emollient from early infancy in 1,247 infants for atopic dermatitis prevention. 2025.

19. Kono et al. Review of ceramide-containing moisturizer evidence in atopic dermatitis. 2021.

20. Cochrane systematic review of rosacea treatment interventions, describing incompletely understood pathophysiology, including innate immune, neurovascular, and barrier-dysfunction mechanisms.

21. Review of cold-sensing neuroreceptor (TRPM8/TRPA1) hypotheses in rosacea pathogenesis, concluding direct human evidence remains limited and is largely extrapolated from animal models. 2026.

22. Nobeyama, et al. Review of rosacea triggers and multifactorial pathophysiology, including temperature fluctuations, sunlight, and airborne exposures. 2024.

23. Engebretsen, K. A., J. Johansen, S. Kežić, A. Linneberg, and J. P. Thyssen. "The effect of environmental humidity and temperature on skin barrier function and dermatitis." Journal of the European Academy of Dermatology and Venereology 30 (2016). https://doi.org/10.1111/jdv.13301.

24. Nugroho, Wisnu Triadi, S. Sawitri, A. Astindari, B. Utomo, Evy Ervianti, and Linda Astari. "The Efficacy of Moisturisers Containing Ceramide Compared with Other Moisturisers in the Management of Atopic Dermatitis: A Systematic Literature Review and Meta-Analysis." Indian Journal of Dermatology 68 (2023): 53 - 58. https://doi.org/10.4103/ijd.ijd_991_22.

25. Kim, B., Jessica W Hui-Beckman, T. Lyubchenko, C. Hall, Sahand Fallahi, A. Brull, E. Goleva, and D. Leung. "Transient Receptor Potential Vanilloid 1 Plays a Major Role in Low Temperature-Mediated Skin Barrier Dysfunction.." The Journal of allergy and clinical immunology (2022). https://doi.org/10.1016/j.jaci.2022.01.027.

26. Green, M., N. Kashetsky, A. Feschuk, and H. Maibach. "Transepidermal water loss (TEWL): Environment and pollution—A systematic review." Skin Health and Disease 2 (2022). https://doi.org/10.1002/ski2.104.